BioQuest, Inc. Acquires BotMakers, Inc. to Revolutionize Conversational AI
BioQuest (OTC PINK:BQST) has completed its acquisition of BotMakers, a leader in AI-powered conversational technology, and appointed Trent T. Daniel as CEO. The company, trading above $1 per share, previously secured SEC clearance for a $5 million Regulation A offering to fund marketing and platform development.
BotMakers expects to generate revenues exceeding $1.2 million this year, targeting $5 million by end-2026. The company serves notable clients including Infinity Concepts and Colonial Stock Transfer. BotMakers secured a contract with 3Mark Financial for implementing conversational AI technology.
BioQuest plans to rebrand as BotMakers and is negotiating to acquire an AI-powered marketing leads company generating over $1 million in annual revenue. The acquisition strengthens BioQuest's position in enterprise-level AI solutions and automated digital workforce solutions for government, corporate, and law enforcement sectors.
BioQuest (OTC PINK:BQST) ha completato l'acquisizione di BotMakers, leader nella tecnologia conversazionale basata su AI, e ha nominato Trent T. Daniel come CEO. L'azienda, che scambia a oltre $1 per azione, ha precedentemente ottenuto l'approvazione dalla SEC per un'offerta di $5 milioni ai sensi della Regolamentazione A per finanziare marketing e sviluppo della piattaforma.
BotMakers prevede di generare entrate superiori a $1,2 milioni quest'anno, puntando a $5 milioni entro la fine del 2026. L'azienda serve clienti di spicco tra cui Infinity Concepts e Colonial Stock Transfer. BotMakers ha ottenuto un contratto con 3Mark Financial per l'implementazione della tecnologia AI conversazionale.
BioQuest prevede di riqualificarsi come BotMakers e sta negoziando per acquisire un'azienda di marketing basata su AI che genera oltre $1 milione di entrate annuali. Questa acquisizione rafforza la posizione di BioQuest nelle soluzioni AI a livello enterprise e nelle soluzioni di forza lavoro digitale automatizzata per i settori governativo, aziendale e delle forze dell'ordine.
BioQuest (OTC PINK:BQST) ha completado su adquisición de BotMakers, un líder en tecnología conversacional impulsada por IA, y ha nombrado a Trent T. Daniel como CEO. La empresa, que cotiza a más de $1 por acción, había asegurado previamente la aprobación de la SEC para una oferta de $5 millones bajo la Regulación A para financiar marketing y desarrollo de la plataforma.
BotMakers espera generar ingresos superiores a $1,2 millones este año, con un objetivo de $5 millones para finales de 2026. La compañía atiende a clientes destacados como Infinity Concepts y Colonial Stock Transfer. BotMakers ha asegurado un contrato con 3Mark Financial para implementar tecnología de IA conversacional.
BioQuest planea rebrandearse como BotMakers y está negociando para adquirir una empresa de generación de leads de marketing basada en IA que genera más de $1 millón en ingresos anuales. La adquisición refuerza la posición de BioQuest en soluciones de IA a nivel empresarial y en soluciones de fuerza laboral digital automatizada para los sectores gubernamental, corporativo y de aplicación de la ley.
BioQuest (OTC PINK:BQST)는 AI 기반 대화형 기술의 선두주자인 BotMakers를 인수했으며, Trent T. Daniel을 CEO로 임명했습니다. 주가는 $1 이상에서 거래되고 있으며, 마케팅 및 플랫폼 개발을 위한 $500만의 규제 A 제안에 대해 SEC 승인을 받았습니다.
BotMakers는 올해 $120만 이상의 수익을 창출할 것으로 예상하며, 2026년 말까지 $500만을 목표로 하고 있습니다. 이 회사는 Infinity Concepts 및 Colonial Stock Transfer와 같은 저명한 고객을 보유하고 있습니다. BotMakers는 3Mark Financial과 대화형 AI 기술 구현을 위한 계약을 체결했습니다.
BioQuest는 BotMakers로 브랜드를 변경할 계획이며, 연간 $100만 이상의 수익을 창출하는 AI 기반 마케팅 리드 회사 인수를 협상 중입니다. 이 인수는 정부, 기업 및 법 집행 부문을 위한 엔터프라이즈 수준의 AI 솔루션 및 자동화된 디지털 인력 솔루션에서 BioQuest의 입지를 강화합니다.
BioQuest (OTC PINK:BQST) a finalisé l'acquisition de BotMakers, un leader dans la technologie conversationnelle alimentée par l'IA, et a nommé Trent T. Daniel en tant que PDG. L'entreprise, dont le cours est supérieur à 1 $ par action, a précédemment obtenu l'approbation de la SEC pour une offre de 5 millions de dollars dans le cadre de la réglementation A pour financer le marketing et le développement de la plateforme.
BotMakers s'attend à générer des revenus dépassant 1,2 million de dollars cette année, visant 5 millions de dollars d'ici la fin de 2026. L'entreprise sert des clients notables tels qu'Infinity Concepts et Colonial Stock Transfer. BotMakers a sécurisé un contrat avec 3Mark Financial pour la mise en œuvre de la technologie IA conversationnelle.
BioQuest prévoit de se renommer BotMakers et est en négociation pour acquérir une entreprise de génération de leads marketing alimentée par l'IA, générant plus de 1 million de dollars de revenus annuels. Cette acquisition renforce la position de BioQuest dans les solutions IA de niveau entreprise et les solutions de main-d'œuvre numérique automatisée pour les secteurs gouvernementaux, corporatifs et des forces de l'ordre.
BioQuest (OTC PINK:BQST) hat die Übernahme von BotMakers, einem führenden Anbieter von KI-gestützter Konversationstechnologie, abgeschlossen und Trent T. Daniel zum CEO ernannt. Das Unternehmen, das über $1 pro Aktie handelt, hat zuvor die Genehmigung der SEC für ein Angebot über $5 Millionen gemäß Regulation A zur Finanzierung von Marketing und Plattformentwicklung erhalten.
BotMakers erwartet, in diesem Jahr Umsätze von über $1,2 Millionen zu generieren, mit dem Ziel, bis Ende 2026 $5 Millionen zu erreichen. Das Unternehmen bedient namhafte Kunden wie Infinity Concepts und Colonial Stock Transfer. BotMakers hat einen Vertrag mit 3Mark Financial zur Implementierung von KI-gestützter Konversationstechnologie gesichert.
BioQuest plant, sich als BotMakers neu zu positionieren und verhandelt über die Übernahme eines KI-gestützten Unternehmens zur Generierung von Marketing-Leads, das jährlich über $1 Million Umsatz erzielt. Die Übernahme stärkt die Position von BioQuest im Bereich der KI-Lösungen auf Unternehmensebene und automatisierten digitalen Arbeitskräften für Regierungs-, Unternehmens- und Strafverfolgungssektoren.
- Expected revenue of $1.2 million in 2025 with projection of $5 million by 2026
- Secured high-profile contract with 3Mark Financial
- Strong existing client base across diverse industries
- SEC-cleared $5 million Regulation A offering for growth funding
- Potential acquisition of $1M revenue generating AI marketing leads company
- Trading on OTC Pink markets, indicating higher risk
- Potential dilution from $5 million Regulation A offering
- Integration risks from multiple planned acquisitions
Trent T. Daniel Named CEO to Lead Sales, Branding and Expansion Initiatives
KATY, TX / ACCESS Newswire / March 19, 2025 / BioQuest, Inc. (OTC PINK:BQST), a publicly traded company on the OTC Markets, has officially completed its acquisition of BotMakers, Inc., a leader in AI-powered conversational technology. This strategic move strengthens BioQuest's position in the AI automation sector and marks a significant step toward its long-term vision of becoming a dominant player in enterprise-level AI solutions. With this acquisition, BioQuest has appointed Trent T. Daniel as its new Chief Executive Officer, effective immediately.
BioQuest has recently been trading at over
BotMakers, Inc. has built a strong reputation for delivering enterprise-grade AI voice and messaging automation. With growing demand and a robust pipeline of contracts, the company expects to generate revenues exceeding
"This acquisition represents a major step forward for BioQuest as we embrace AI-driven automation," said Trent T. Daniel, CEO of BioQuest. "With BotMakers' technology and expertise, we are well-positioned to scale our offerings and drive innovation in the enterprise AI space. Our mission is to provide businesses with intelligent, automated solutions that redefine operational efficiency."
Further solidifying its presence in the AI sector, BotMakers has secured a high-profile contract with 3Mark Financial, one of the nation's largest life insurance wholesalers, to implement its state-of-the-art conversational AI technology. This partnership highlights the growing demand for AI-driven automation in financial services and beyond.
Looking ahead, BioQuest plans to rebrand as BotMakers, Inc. to better align with its core expertise in AI innovation. The company is also in active negotiations to acquire an AI-powered marketing leads company, which currently generates over
For more information, please visit www.botmakers.ai or contact:
Media Contact
Tamares Davis
tdavis@botmakers.ai
1-866-753-8002
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:* This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about BioQuest, Inc.'s and BotMakers, Inc.'s industry, management's beliefs, and certain assumptions made by the company. Forward-looking statements are typically identified by words such as "anticipates," "believes," "expects," "intends," "plans," "projects," "seeks," "estimates," and similar expressions.
These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond the company's control, that could cause actual results to differ materially from those expressed or implied in these statements. These risks and uncertainties include, but are not limited to, general economic conditions, changes in industry trends, competitive pressures, regulatory changes, and the company's ability to secure additional contracts and strategic partnerships.
Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. BioQuest, Inc. and BotMakers, Inc. undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
SOURCE: BioQuest
View the original press release on ACCESS Newswire
FAQ
What is the expected revenue for BioQuest (BQST) in 2025?
How much funding did BQST secure through its Regulation A offering?
Which major client did BioQuest's BotMakers secure a contract with?
What is BioQuest's (BQST) revenue target for 2026?
What strategic acquisition is BQST currently negotiating?
